Cargando…

ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding

Rho GTPase activating protein 26 (ARHGAP26) is a negative regulator of the Rho family that converts the small G proteins RhoA and Cdc42 to their inactive GDP-bound forms. It is essential for the CLIC/GEEC endocytic pathway, cell spreading, and muscle development. The present study shows that ARHGAP2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiong, Hui, Haipeng, Guo, Zhendong, Zhang, Weina, Hu, Yaou, He, Tao, Tai, Yanhong, Peng, Peng, Wang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851720/ https://www.ncbi.nlm.nih.gov/pubmed/24067935 http://dx.doi.org/10.1261/rna.041533.113

Ejemplares similares

MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis
por: Danza, Katia, et al.
Publicado: (2014)

ADAR2-Mediated Editing of miR-214 and miR-122 Precursor and Antisense RNA Transcripts in Liver Cancers
por: Liu, Wan-Hsin, et al.
Publicado: (2013)

miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition
por: Wang, Lin, et al.
Publicado: (2015)

miR-573 regulates cell proliferation and apoptosis by targeting Bax in nucleus pulposus cells
por: Wang, Rui, et al.
Publicado: (2019)

miR-337-3p inhibits gastric tumor metastasis by targeting ARHGAP10
por: Wang, Zishu, et al.
Publicado: (2020)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells
por: Ichikawa, Takehiro, et al.
Publicado: (2012)

ADAR1 Alleviates Inflammation in a Murine Sepsis Model via the ADAR1-miR-30a-SOCS3 Axis
por: Shangxun, Zhou, et al.
Publicado: (2020)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Combined detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for screening of early heart failure diseases
por: Ding, Han, et al.
Publicado: (2020)

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

Evaluation of miR-141, miR-200c, miR-30b Expression and Clinicopathological Features of Bladder Cancer
por: Mahdavinezhad, Ali, et al.
Publicado: (2015)

MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin
por: Huang, Nunu, et al.
Publicado: (2015)

Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer
por: Torbati, Peyman Mohammadi, et al.
Publicado: (2019)

Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer
por: Yang, Jia, et al.
Publicado: (2021)

MiR-573 suppresses cell proliferation, migration and invasion via regulation of E2F3 in pancreatic cancer
por: Pengcheng, Zhou, et al.
Publicado: (2021)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
por: Ni, Qingtao, et al.
Publicado: (2018)

Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
por: Wang, Tongfei, et al.
Publicado: (2021)

Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction
por: Li, Chencheng, et al.
Publicado: (2015)

miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
por: Varendi, Kärt, et al.
Publicado: (2014)

ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity
por: Ramírez-Moya, Julia, et al.
Publicado: (2020)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

Association of miR-21, miR-126 and miR-605 gene polymorphisms with ischemic stroke risk
por: Xiang, Yang, et al.
Publicado: (2017)

Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction
por: Bukauskas, Tomas, et al.
Publicado: (2019)

The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene
por: Tormo, Eduardo, et al.
Publicado: (2017)

Expression levels of miR-22, miR-30c, miR-145, and miR-519d and their possible associations with inflammatory markers among patients with coronary artery disease
por: Ghorbani, Saied, et al.
Publicado: (2022)

Decreased Expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4(+) T Cells and Peripheral Blood from Tuberculosis Patients
por: Kleinsteuber, Katja, et al.
Publicado: (2013)

Expression Patterns of miR181a and miR30d in Patients with Breast Cancer
por: Tavakolpournegari, Alireza, et al.
Publicado: (2022)

ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism
por: Widmark, Albin, et al.
Publicado: (2022)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)

MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals
por: Ying, Hou-Qun, et al.
Publicado: (2016)

miR-24, miR-30b and miR-142-3p interfere with antigen processing and presentation by primary macrophages and dendritic cells
por: Naqvi, Afsar Raza, et al.
Publicado: (2016)

Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
por: Ni, Qingtao, et al.
Publicado: (2019)

miR-26a and miR-384-5p are required for LTP maintenance and spine enlargement
por: Gu, Qin-Hua, et al.
Publicado: (2015)

miR-939-5p Contributes to the Migration and Invasion of Pancreatic Cancer by Targeting ARHGAP4
por: Shen, Yehua, et al.
Publicado: (2020)

RELA-induced MiR-21 Exerts Oncogenic Effects on PDAC via Targeting of ARHGAP24
por: Yu, Lanting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eq3peff0pi3o3u625odvif47i6